Drug recall · September 27, 2017
Levophed recall
Why: Lack of sterility assurance: resulting from use of a damaged sterilizing filter for nitrogen used in the manufacturing process.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Levophed (norepinephrine bitartrate) injection, USP, 4 mg/4 mL (1mg/mL), 4mL Fill in 5 mL Single dose Fliptop Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-3375-04
- Lots / codes
Lot #: 753003A, Exp 9/18; 762153A, 760803A, 761053A , Exp 10/18
- Quantity
- 98,050 vials
- Company
- Pfizer Inc., New York, NY
- Distribution
- United States Nationwide (including Puerto Rico) and Singapore
- Initiated
- August 22, 2017 · Voluntary: Firm initiated
- Classified
- September 15, 2017
- Reported
- September 27, 2017
- Ended
- February 19, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Norepinephrine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.